Article
Pharmacogenomic insights into treatment and management of statin-induced myopathy
1 Jan 2009
Abstract excerpt
Although statins are generally well tolerated, the most common adverse drug reaction from statin therapy is myopathy. This article reviews the current pharmacogenomic knowledge of statin-induced myopathy. Furthermore, we will discuss the importance of recent pharmacogenetic advances for the treatment and management of statin-induced myopathy. Variation in the SLCO1B1 gene is associated with increased incidence of...
Topics
Join the communities discussing this publication.